Prostate.Carcinoma.ai

The DICOM connected AI plug-in to facilitate your PI-RADS v2.1 workflow
integrated in mint Lesion

Our features

Automated segmentation of the prostate gland and suspicious lesions in the T2-weighted image series

Automatic determination of prostate volume and facilitated calculation of PSA density

Classification into potential malignant and potential benign lesions

Easy to edit by the end-user

Generation of structured PI-RADS v2.1 report via mint Lesion

Your Benefits

Quicker focus on relevant regions of interest¹
Shorter MRI analysis time and increased efficiency¹
Less manual work¹
More accurate prostate volumetry¹

[1] F. Burn et al. (2025). Manuscript to be submitted to a peer-reviewed journal.

Automated segmentation of the prostate gland

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Automated prostate volumetry

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Automated calculation of PSA density

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Automated segmentation of suspicious lesions

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Easy to edit by the end-user

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Classification into potential malignant and potential benign lesions

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Automatic calculation of lesion size and volume

The above figure shows a product feature of Prostate.Carcinoma.ai integrated in mint Lesion™
Generation of editable structured PI-RADS 2.1 report via mint Lesion

References

Dr. med Alexander Cornelius, Head of Urogenital Imaging, Kantonsspital Aarau, Switzerland

“Structured prostate MRI reporting is essential—mint Lesion and the FUSE-AI algorithm together significantly boost efficiency and objectivity. I clearly recommend using both systems.“
Dr. med. Felice Burn, Radiologist, Kantonsspital Aarau, Switzerland

"Developing innovative healthcare solutions requires strategic collaboration with capable and motivated partners who can meet challenges and drive the digital transformation of radiology. FUSE-AI is committed to enhance MRI analysis with high-quality, impactful solutions."
Prof. Dr. med. Tobias Franiel, Head of Oncologic and Urogenital Imaging, University Hospital Jena, Germany

“The results of our joint study indicate that AI-assisted biparametric MRI using Prostate.Carcinoma.ai definitely is an alternative to multiparametric MRI for the detection of prostate cancer.“
Prof. Dr. Thorsten Persigehl, Head of Oncologic Imaging, University Hospital Cologne, Germany

"Prostate.Carcinoma.ai clearly reduces the radiologist's workload by automatically segmenting and volumetrizing the prostate. The integration in mint Lesion offers a high level of user-friendliness and enables the PI-RADS report to be generated within just a few clicks."
Mathias Seitel, Head of Product Management, Mint Medical GmbH, Germany

“Integrating Prostate.Carcinoma.ai into mint Lesion is a logical step toward our goal: empowering radiologists with intelligent tools to meet the demands of value-based care.”
Steffen Rupp, Senior Director Healthcare Sales, Mint Medical GmbH, Germany

“Through our partnership with FUSE-AI and the integration of mint Lesion with Prostate.Carcinoma.ai, we combine the advantages of structured reporting with those of automated image recognition. This enhances standardization, reproducibility, and quality of radiological findings, while also delivering significant gains in reporting efficiency.”